O’Melveny Represents Acotec Scientific in US$210 Million Hong Kong IPO
August 24, 2021
FOR IMMEDIATE RELEASE
HONG KONG—AUGUST 24, 2021—O’Melveny recently represented Acotec Scientific Holdings Limited (6669.HK) in its HK$1.63 billion (approximately US$210 million) initial public offering and listing of shares on the Hong Kong Stock Exchange. Assuming full exercise of the over-allotment option, the offering size will be HK$1.88 billion (approximately US$242 million).
O’Melveny advised Acotec on both Hong Kong and U.S. laws. Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited acted as the joint sponsors and joint global coordinators.
Founded in 2011, Acotec is a leading innovative medical device company in China, and a dominant leader in the peripheral interventional medical device market in China. It focuses on providing “leave nothing behind” treatment solutions for vascular diseases, and has developed a suite of interventional medical devices featuring world-leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters.
The O’Melveny team was led by corporate partners Ke Geng and Ke Zhu, and included counsel Ye Sun and Wei Liu, associates Weigang Meng, Katherine Wang, and Hilda Leung, as well as legal consultants Lu Yu, Rita Deng, Ningzhi Chen, and Kaikai Liu. Partner Luc Moritz, counsel Billy Abbott and Ella Ge, and associate Dawn Lim also provided valuable support.
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com or learn more in our firm at-a-glance, year-end highlights, and on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
O’Melveny & Myers LLP
+1 212 326 2218
O’Melveny & Myers LLP
+86 21 2307 7000